The treatment with D + Q was able to reduce MCP-1 release in normal but not in IPF fibroblast, while SOC drugs showed no effect neither in normal nor IPF senescent fibroblast (Fig. 6c). The gene discussed is UBXN11; the disease is idiopathic pulmonary fibrosis.